RAMM Pharma Corp. (CSE:RAMM)

Market Cap	1.79M -86.7%
Revenue (ttm)	2.56M -41.7%
Net Income	-8.65M
EPS	-0.07
Shares Out	119.39M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	61,000
Open	0.0100
Previous Close	0.0150
Day's Range	0.0100 - 0.0150
52-Week Range	0.0100 - 0.2500
Beta	0.55
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 26, 2026

About RAMM Pharma

RAMM Pharma Corp., together with its subsidiaries, operates in the pharmaceutical and medical product business in Uruguay and Poland. The company offers cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products; and pharmaceuticals, cosmetics, and nutraceutical products. It also engages in the resale of medical supplies products; and the sale of medical devices and consumables. The company was formerly known as MTC Growth Fund-I Inc. and changed its name to RAMM Pharma Corp. in October...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1987
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: RAMM

Financial Performance

In fiscal year 2025, RAMM Pharma's revenue was 3.36 million, a decrease of -22.60% compared to the previous year's 4.34 million. Losses were -8.91 million, -46.01% less than in 2024.